大鼠肾周脂肪组织趋化因子样受体1过表达对非酒精性脂肪性肝炎的影响*

doi:10.3969/j.issn.1672-5069.2016.03.007

摘要/Abstract

摘要： 目的探讨慢病毒介导的趋化因子样受体1（CMKLR1) 在大鼠肾周脂肪组织中过表达对非酒精性脂肪性肝炎的影响。方法将42只雄性SD大鼠随机分为对照组、模型组、转染组各12只和空转染组6只。给予对照组普通饮食喂养，给予其余组高脂饮食喂养。在造模开始时给予各组经尾静脉注射溶媒和真病毒或空病毒。在实验第8 w和12 w，分批处死大鼠，取肝组织行苏木精-伊红染色，观察组织病理学变化；采用酶联免疫吸附法测定血清凯莫瑞和脂联素水平；分别采用RT-PCR法和Western blot法测定肾周脂肪组织CMKLR1和脂联素mRNA和它们的蛋白表达。结果模型组大鼠肝组织炎症程度明显于对照组和转染组；在实验8 w和12 w，模型组血清凯莫瑞水平分别为（4.65±0.48） mmol/L和 (4.47±0.37）mmol/L，与对照组水平无明显差异[（4.38±0.43）mmol/L和（4.16±0.27）mmol/L]，但均显著低于转染组水平[（7.66±0.53）mmol/L和（6.74±0.59）mmol/L，P<0.05]；在8 w时，模型组脂肪组织CMKLR1 mRNA及其蛋白相对量分别为（0.235±0.008）和（0.206±0.005），与对照组水平无显著差异[（0.226±0.008）和（0.21±0.117）]，但显著低于转染组水平[（0.579±0.016）和（0.504±0.121），P＜0.05]；第12 w时，脂肪组织CMKLR1 mRNA及其蛋白表达水平与第8 w时结果相似；在8 w时，模型组大鼠血清脂联素水平、脂肪组织脂联素 mRNA及其蛋白表达水平分别为[【（31.82±1.51）mmol/L、（0.126±0.005）和（0.14±0.008）]，显著低于对照组[（37.92±4.09）mmol/L、（0.262±0.007）和（0.35±0.016），P<0.05]和转染组水平[（36.50±2.43）mmol/L、（0.193±0.058）和（0.232±0.012），P<0.05]；在12 w时，所测血清脂联素水平、脂肪组织脂联素 mRNA水平及其蛋白表达水平与第8 w时结果相似。结论慢病毒介导的大鼠脂肪组织内过表达CMKLR1可显著改善大鼠非酒精性脂肪性肝炎时肝组织病理学损害。

关键词: 非酒精性脂肪性肝炎, 趋化因子样受体1, 凯莫瑞, 脂联素, 大鼠

Abstract: Objective To study the role of chemokine-like receptor 1（CMKLR1） over-expression evoked by lentivirus in the adipose tissues of rats with nonalcoholic steatohepatitis（NASH）. Method 42 male SD rats were randomly divided into four groups. Rats in control group （n=6） fed with normal diet，and rats in other three fed with high fat diet. Vehicle，CMKLR1 virus （2×109pfu） or control virus （2×109pfu） was injected via tail vein at the first day of experiment. Rats were sacrificed at the end of 8 and 12 weeks. The pathological changes of liver tissues were observed. Kay Murray and adiponectin in serum were measured，and the levels of adiponectin in adipose tissues and the mRNA and its protein levels of CMKLR1 in adipose tissues were detected by RT-PCR or Western blot. Results The pathological inflammation in liver tissues of rats with CMKLR1 overexpression was significantly improved as compared with that in the controls or rats with control virus；The serum levels of chemerin at 8 and 12 weeks were（4.65±0.48） mmol/L and（4.47±0.37）mmol/L），respectively，similar to those in the controls[（4.38±0.43） mmol/L and （4.16±0.27）mmol/L]，and were significantly lower than those in rats with CMKLR1 overexpression [（7.66±0.53）mmol/L and （6.74±0.59）mmol/L，respectively，P＜0.05]；CMKLR1 mRNA and its protein in model group at 8 weeks were （0.235±0.008） and （0.206±0.005），respectively，similar to those in the controls[（0.226±0.008） and （0.21±0.117）]，and they were significantly lower than those in rats with CMKLR1 overexpression [（0.579±0.016） and （0.504±0.121），respectively，P＜0.05]；A similar changes in CMKLR1 mRNA and its protein were observed at 12 weeks；At 8 weeks，serum adiponectin，adiponectin mRNA and its protein in model group were [（31.82±1.51）mmol/L，（0.126±0.005） and（0.14±0.008）]，which were significantly lower than those in the controls at the same period [（37.92±4.09）mmol/L，（0.262±0.007） and（0.35±0.016），P<0.05]，and those in the transfection group[（36.50±2.43）mmol/L，（0.193±0.058） and（0.232±0.012），P<0.05]；A similar changes in serum adiponectin，adiponectin mRNA and its protein were observed at 12 weeks. Conclusion CMKLR1 over- expression evoked by lentivirus transfection could improve pathological inflammation in rats with NASH.

Key words: Non-alcoholic steatohepatitis, Chemokine-like receptor 1, Chemerin, Adiponectin, Rats

安秀琴，郭巧利，刘近春，郭峰涛，郭亚荣. 大鼠肾周脂肪组织趋化因子样受体1过表达对非酒精性脂肪性肝炎的影响*[J]. 实用肝脏病杂志, 2016, 19(3): 279-282.

An Xiuqin,Guo Qiaoli,Liu Jinchun,et al.. Role of CMKLR1 over-expression in adipose tissues in rat with nonalcoholic steatohepatitis[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(3): 279-282.

参考文献

[1] Ludwig J，Viggiano TR，McGill DB. Nonalcoholic seatohepatitis: Mayo clinic experiences with a hitherto unnamed disease. Mayo Clin Proc，1980，55（7）：434-438.
[2] 段晓燕，范建高.2010欧洲肝病学会非酒精性脂肪性肝病专家共识简介. 中国医学前沿杂志（电子版），2012，4（7）：14-21.
[3] D cke S，Lock JF，Birkenfeld AL. Elevated hepatic chemerin mRNA expression in human non-alcoholic fatty liver disease.Eur J Endocrinol，2013，169（5）：547-557.
[4] Kucera O，Cervinkova Z. Experimental models of non-alcoholic fatty liver disease in rats. World J Gastroenterol，2014，20（26）:8364-8376.
[5] Yang HS，Li FN，Kong XF，et al. Molecular cloning，tissue distribution and ontogenetic expression of Xiang pig chemerin and its involvement in regulating energy metabolism through Akt and ERK1/2 signaling pathways.Mol Biol Rep，2012，39（2）:1887-1894.
[6] Muruganandan S，Roman AA，Sinal CJ，et al．Role of chemerin /CMKLR1 signaling in adipogenesis and osteoblastogenesis of bone marrow stem cells. J Bone Min Res，2010，25（2）:222-223.
[7] Gantz L，Konda Y，Yang YK，et al. Molecular cloning of a novel receptor （CMKLR1） with homology to the chemotactic factor receptors. Cytogenet Cell Genet，1996，74（4）:286-290.
[8] Kukla M，Zwirska-Korczala K，Gabriel A，et al．Chemerin，vaspin and insulin resistance in chronic hepatitis C. J Viral Hepat，2010，17（9）:661-667．
[9] Nakajima H，Nakajima K，Nagano Y，et al．Circulating level of chemerin is upregulated in psoriasis．J Dermatol Sci，2010，60（1）:45-47．
[10] Bauer S，Wanninger J，Schmidhofer S，et al. Sterol regulatory element-binding protein 2（SREBP2） activation after excess triglyceride storage induces chemerin in hypertrophic adipocytes. Endocrinology，2011，152（1）:26-35.
[11] Bozaoglu K，Bolton K，McMillan J，et al. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology，2007，148（10）:4687-4694.
[12] Ernst MC，Issa M，MGoralski KB. Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes.Endocrinology，2010，1521（5）:1998-2007.
[13] Yan QD，Chertov O，Oppenheim JJ，et al．The role of mamma1ian an timierobia1 peptides and proteins in awakening of innate host defenses and adaptive inununity cell．Cell MolLife Sci，2001，58（7）:978-989．
[14] Cash JL，Hart R，Russ A，et al．Synthetic chemerin derived peptides suppress inflammation through ChemR23．J Exp Med，2008，205（4）:767-775．
[15] Qi GM，Jia LX，Li YL，et al. Adipotion suppresses aniotention II-induced inflammation and cardiac fibrosis through activation of macrophage autophagy. Endocrinology，2014，155（6）:2254-2265.
[16] Liu H，Liu JS，Huang J. Unique association of adiponectin isoforms with serum cytokines and redox molecules in patients with chronic obstructive pulmonary disease. Chin Med J2013，126（17）:3383-3384.